Paper Details

  1. Home
  2. Paper Details

MAOIs and transdermal delivery.

Author: VandenbergChad M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

MAOIs are effective antidepressants, particularly for atypical or treatment-resistant depression, but they have safety and tolerability concerns. A transdermal formulation of selegiline delivers the medication directly into the circulatory system, bypassing the first-pass metabolism of the GI system and substantially reducing the risk for tyramine-related adverse events. This allows for a lower dose to achieve an antidepressant effect, maintains a steady dose of the medication over 24 hours, and avoids the need for dietary restrictions.
Paper Details　
Original Abstract of the Article :
Although not currently considered a first-line treatment for depression due to safety and tolerability concerns, MAOIs are effective antidepressants, particularly for atypical or treatment-resistant depression. FDA-approved oral MAOIs inhibit both MAO-A and MAO-B; inhibition of MAO-A in the brain is...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.4088/JCP.11096tx6c

データ提供：米国国立医学図書館（NLM）

MAOIs: A New Path to Treatment for Depression

The study, "MAOIs and transdermal delivery," explores the use of monoamine oxidase inhibitors (MAOIs) in the treatment of depression, particularly atypical or treatment-resistant depression. It's like discovering a hidden trail in a vast desert, revealing a new and potentially effective route for addressing a challenging condition.

Transdermal Delivery: A New Approach

The study highlights the potential benefits of transdermal delivery of selegiline, an MAOI, over oral administration. This is like finding a more efficient way to transport water across a desert, ensuring the medication reaches its destination with minimal loss. Transdermal delivery bypasses the first-pass metabolism of the gastrointestinal system, reducing the risk of tyramine-related adverse events and allowing for lower doses. This approach offers a potentially safer and more effective treatment option for individuals with depression.

Navigating the Challenges of Depression

This research underscores the importance of exploring new approaches to treating depression, particularly for individuals who do not respond to traditional therapies. It's like seeking out new routes across a challenging desert landscape, constantly searching for more effective solutions. This study highlights the potential of MAOIs, particularly through transdermal delivery, to offer a new avenue for treating depression.

Dr. Camel's Conclusion

This study, like a guidepost in the vast desert of depression, offers valuable insights into the potential of MAOIs, particularly through transdermal delivery. This approach offers a potentially safer and more effective alternative for individuals with depression, particularly those who have not responded to traditional therapies. This research underscores the importance of ongoing research and innovation in the field of mental health, continuously seeking new solutions to address the challenges of depression.

Date :
  1. Date Completed 2012-12-26
  2. Date Revised 2013-02-05
Further Info :

Pubmed ID

23059160

DOI: Digital Object Identifier

10.4088/JCP.11096tx6c

Related Literature

Article Analysis
・Effects of selegiline transdermal patch
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.